Expertise in
1
conditions

Dr. Julie A. Taguchi

Oncology
Sansum Clinic
317 W Pueblo St, 
Santa Barbara, CA 
Expertise in
1
conditions
Sansum Clinic
317 W Pueblo St, 
Santa Barbara, CA 

Overview

Julie Taguchi is an Oncologist practicing medicine in Santa Barbara, California.

Dr. Taguchi is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer.

She is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 2 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in CA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

Sansum Clinic
317 W Pueblo St, Santa Barbara, CA 93105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

FOCUS: A Multicenter, Multinational, Double-Blind, 2-Arm, Randomized, Phase 2/3, Study of Physician's Choice Chemotherapy ([PCC] Weekly Paclitaxel or Pegylated Liposomal Doxorubicin [PLD]) Plus Bevacizumab and CA4P Versus PCC Plus Bevacizumab and Placebo for Subjects With Platinum-Resistant, Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
FOCUS: A Multicenter, Multinational, Double-Blind, 2-Arm, Randomized, Phase 2/3, Study of Physician's Choice Chemotherapy ([PCC] Weekly Paclitaxel or Pegylated Liposomal Doxorubicin [PLD]) Plus Bevacizumab and CA4P Versus PCC Plus Bevacizumab and Placebo for Subjects With Platinum-Resistant, Recurrent Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Enrollment Status: Terminated
Publish Date: March 24, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Presurgical Tissue-Acquisition Study to Evaluate Molecular Alterations in Human Breast Cancer Tissue Following Short-Term Exposure to the Androgen Receptor Antagonist Darolutamide (ODM-201)
A Presurgical Tissue-Acquisition Study to Evaluate Molecular Alterations in Human Breast Cancer Tissue Following Short-Term Exposure to the Androgen Receptor Antagonist Darolutamide (ODM-201)
Enrollment Status: Completed
Publish Date: April 03, 2020
Intervention Type: Drug
Study Phase: Early Phase 1
View 1 Less Clinical Trial

3 Total Publications

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09).
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09).
Journal: Therapeutic advances in medical oncology
Published: May 28, 2018
Similar Doctors
Expertise in
35
conditions
Expertise in
35
conditions
Referral may be required

Steven Zelko

309 W Quinto St, 
Santa Barbara, CA 
 (0.2 miles away)
805-563-0041
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Greenwald is an Oncologist practicing medicine in Santa Barbara, California. Dr. Greenwald is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Severe Congenital Neutropenia, Chronic Familial Neutropenia, Non-Hodgkin Lymphoma, and Familial Colorectal Cancer.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Office

111 E Victoria St, 
Santa Barbara, CA 
 (1.0 miles away)
805-563-0041
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Juliet Penn is an Oncologist practicing medicine in Santa Barbara, California. Dr. Penn is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Paget Disease of the Breast, Angiosarcoma, and Bone Marrow Aspiration.

Expertise in
6
conditions
Expertise in
6
conditions
Referral may be required

Steven Zelko

309 W Quinto St, 
Santa Barbara, CA 
 (0.2 miles away)
805-563-0041
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Frederic Kass is an Oncologist practicing medicine in Santa Barbara, California. Dr. Kass is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Pancreatic Cancer.

Frequently Asked Questions about Dr. Julie A. Taguchi

How do I make an appointment with Dr. Julie A. Taguchi?

You can book an appointment with Dr. Julie A. Taguchi by calling their office at 805-898-3270. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Julie A. Taguchi a top-rated expert for Merkel Cell Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Julie A. Taguchi is classified as an Advanced expert for Merkel Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Julie A. Taguchi specialize in?

While Dr. Julie A. Taguchi is a Oncology, they have specific expertise in Merkel Cell Carcinoma, Breast Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Julie A. Taguchi participate in research or clinical trials?

Yes. Dr. Julie A. Taguchi has published 3 articles and abstracts on conditions like Merkel Cell Carcinoma. You can view a list of Dr. Julie A. Taguchi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Julie A. Taguchi accept my insurance?

Dr. Julie A. Taguchi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 805-898-3270 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Taguchi's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile